Corn oil, but not cocaine, is a more effective reinforcer in obese than in lean Zucker rats

Physiology & Behavior
Edward A TownsendKevin B Freeman

Abstract

Obesity is associated with abnormal brain reactivity in response to palatable food consumption, a factor that may contribute to non-homeostatic eating. However, little is known about how obesity interacts with the reinforcing effects of highly palatable constituents of food (e.g., fat), and if altered reinforcement processes associated with obesity generalize to non-food reinforcers. The current study compared the reinforcing effects of a fat (corn oil) and a drug of abuse (cocaine) in obese and lean Zucker rats. Specifically, obese and lean Zucker rats self-administered corn oil or intravenous cocaine in a behavioral economic demand procedure. For corn oil, maximum demand was higher and demand elasticity was lower in the obese rats compared to their lean counterparts. However, there were no differences in demand for cocaine between the obese and lean rats. These results demonstrate that a fat in the form of corn oil is a more effective reinforcer in obese Zucker rats. However, the fact that demand for cocaine was not different between the obese and lean rats suggests that differences in reward mechanisms may be reinforcer-specific and do not necessarily generalize to non-food reinforcers.

References

Oct 1, 1985·Physiology & Behavior·A DrewnowskiM R Greenwood
May 1, 1996·Nature Genetics·M S PhillipsJ F Hess
Mar 25, 1999·Psychopharmacology·M J GlassA S Levine
Jun 11, 2002·Nature Neuroscience·Serge H AhmedAthina Markou
Oct 22, 2002·Expert Opinion on Therapeutic Targets·Gene-Jack WangJoanna S Fowler
Sep 15, 2004·Behavioural Brain Research·Stephanie FultonPeter Shizgal
Jun 10, 2006·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Nu-Chu LiangRalph Norgren
Sep 4, 2007·Pharmacology, Biochemistry, and Behavior·Paul J WellmanKristina W Davis
Jan 24, 2008·Psychological Review·Steven R Hursh, Alan Silberberg
May 14, 2008·International Journal of Obesity : Journal of the International Association for the Study of Obesity·P K ThanosN D Volkow
Jan 28, 2009·Behavioral Neuroscience·Chesley J ChristensenAnthony L Riley
Mar 31, 2009·Physiology & Behavior·Eric SticeDavid H Zald
Aug 3, 2010·Behavioural Processes·Erin B RasmussenConrad Hillman
Aug 24, 2010·Neuropharmacology·Beate C FingerJohn F Cryan
Apr 6, 2011·Archives of General Psychiatry·Ashley N GearhardtKelly D Brownell
Oct 21, 2011·Nature Reviews. Neuroscience·Paul J Kenny
Nov 8, 2011·The Surgical Clinics of North America·Rachel L McKenney, Daniel K Short
Mar 10, 2012·Neuropharmacology·Asaf MarcoAron Weller
Sep 26, 2012·Nature Neuroscience·Ralph J DiLeoneMarina R Picciotto
Nov 24, 2012·Critical Reviews in Biochemistry and Molecular Biology·Dardo Tomasi, Nora D Volkow
Jan 25, 2013·Journal of the Experimental Analysis of Behavior·Steven R Hursh, Peter G Roma
Feb 5, 2013·Biological Psychiatry·Nora D VolkowRuben D Baler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

© 2022 Meta ULC. All rights reserved